James P Mackin Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 months, 2 weeks ago
James P Mackin has an estimated net worth of at least $46.7 million*, as of Oct. 29, 2025. They own 800,993 shares of AORT stock. They have sold 510,614 shares of AORT stock since 2021, for an estimated $8.1 million.
James P Mackin $AORT SEC Form 4 Insider Trading
James P Mackin has filed a total of 26 insider trades in $AORT since 2021. Their most recent trade was a sale of 30,921 shares, made on Dec 03, 2025. Their largest trade was a sale of 70,700 shares, made on Mar 06, 2025. We estimate that they now own 800,993 shares of $AORT, worth an estimated $38.5 million.
Insider Trading at $AORT
There have been a total of 191 insider trades reported at $AORT since 2021, with 0 shares purchased and 1.2 million shares sold. The most active insider traders in $AORT stock have been Jean F Holloway, Marshall S. Stanton, and James P Mackin. The most recent trade was a sale of 5,000 shares reported by John E Davis (Chief Commercial Officer), made on Dec 15, 2025.
History of Insider Stock Trades by James P Mackin
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
AORT
|
Sale | 30,921 | Dec 03, 2025 | Dec. 4, 2025, 9:54 p.m. |
|
AORT
|
Sale | 30,921 | Dec 02, 2025 | Dec. 3, 2025, 8:27 p.m. |
|
AORT
|
Sale | 34,210 | Nov 13, 2025 | Nov. 14, 2025, 1:09 p.m. |
|
AORT
|
Sale | 17,580 | Nov 10, 2025 | Nov. 12, 2025, 9:08 p.m. |
|
AORT
|
Sale | 12,500 | Aug 15, 2025 | Aug. 19, 2025, 11:28 a.m. |
|
AORT
|
Sale | 70,700 | Mar 06, 2025 | March 10, 2025, 5:18 p.m. |
|
AORT
|
Sale | 17,739 | Mar 06, 2025 | March 10, 2025, 5:18 p.m. |
|
AORT
|
Sale | 16,664 | Feb 24, 2025 | Feb. 26, 2025, 3 p.m. |
|
AORT
|
Sale | 4,896 | Feb 24, 2025 | Feb. 26, 2025, 3 p.m. |
|
AORT
|
Sale | 6,812 | Feb 24, 2025 | Feb. 26, 2025, 3 p.m. |
|
AORT
|
Sale | 13,784 | Feb 24, 2025 | Feb. 26, 2025, 3 p.m. |
|
AORT
|
Sale | 13,996 | Mar 05, 2024 | March 7, 2024, 7:20 p.m. |
|
AORT
|
Sale | 4,837 | Feb 27, 2024 | Feb. 29, 2024, 6:36 p.m. |
|
AORT
|
Sale | 13,168 | Feb 26, 2024 | Feb. 28, 2024, 6:22 p.m. |
|
AORT
|
Sale | 18,144 | Feb 26, 2024 | Feb. 28, 2024, 6:22 p.m. |
|
AORT
|
Sale | 2,756 | Feb 20, 2024 | Feb. 22, 2024, 6:08 p.m. |
|
AORT
|
Sale | 59,225 | Feb 20, 2024 | Feb. 22, 2024, 6:08 p.m. |
|
AORT
|
Sale | 10,088 | Feb 20, 2024 | Feb. 22, 2024, 6:08 p.m. |
|
AORT
|
Sale | 9,990 | Mar 02, 2023 | March 3, 2023, 7:07 p.m. |
|
AORT
|
Sale | 12,645 | Feb 27, 2023 | March 1, 2023, 2:36 p.m. |
|
AORT
|
Sale | 9,985 | Feb 27, 2023 | March 1, 2023, 2:36 p.m. |
|
AORT
|
Sale | 56,500 | Feb 14, 2023 | Feb. 16, 2023, 6:36 p.m. |
|
AORT
|
Sale | 10,638 | Feb 09, 2022 | Feb. 11, 2022, 9:41 a.m. |
|
AORT
|
Sale | 10,639 | Feb 10, 2022 | Feb. 11, 2022, 9:41 a.m. |
|
AORT
|
Sale | 10,638 | Feb 08, 2022 | Feb. 10, 2022, 8:53 a.m. |
|
AORT
|
Sale | 10,638 | Feb 07, 2022 | Feb. 8, 2022, 5:38 p.m. |
$AORT Executives and Stock Owners with Insider Trades
-
Jean F Holloway, SVP, General Counsel
-
Marshall S. Stanton, SVP, Clinical & MD Affair
-
James P Mackin, President & CEO
-
Amy Horton, VP, Chief Accounting Officer
-
John E Davis, Chief Commercial Officer
-
Matthew A Getz, VP, Human Resources
-
Andrew M Green, VP Regulatory
-
Dennis B Maier, SVP, Operations
-
Rochelle L. Maney, VP, Quality
-
David Ashley Lee, Executive VP, COO & CFO
-
John E Davis, Senior VP, Global Sales
-
Florian Tyrs, VP, Global Operations
-
Lance A Berry, Executive VP, CFO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.